Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03474276
Other study ID # 2014-062
Secondary ID FPC N° 2013-4025
Status Completed
Phase Phase 3
First received
Last updated
Start date January 31, 2018
Est. completion date June 30, 2019

Study information

Verified date May 2022
Source Institut Pasteur
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this open-label randomized controlled trial conducted in four African countries (Madagascar, Niger, Central African Republic and Senegal) is to compare three strategies of renutrition for moderate acute malnutrition (MAM) in children based on modulation of the gut microbiota with enriched flours alone, enriched flours with prebiotics or enriched flours coupled with antibiotic treatment. Cognitive development of children (Senegal) will also be studied and compared.


Description:

The main objective of this study is to improve the nutrition strategy used to take in charge moderate acute malnutrition (MAM) which is the major milestone before severe malnutrition. This will be based on the modulation of the gut microbiota with adjunct product added to standard nutrition flours. The purpose of the MALINEA study is to compare three management strategies for Moderate Acute Malnutrition (MAM) in children aged between 6 months and 2 years old on recovery defined by a weight/size gain at 3 months. The 3 groups will be compared on several anthropometric measurements [Weight, length, Mid Upper Arm Circumference (MUAC)], clinical characteristics, adherence and tolerance to interventions between before and after a 3 months intervention Cognitive development of children (Senegal) will also be studied and compared, at inclusion, 3 months and 6 months after inclusion. The investigators will also investigate the microbiomes of malnourished children at inclusion and at 3 and 6 months after inclusion to compare it to the ones of normonourished children.


Recruitment information / eligibility

Status Completed
Enrollment 1357
Est. completion date June 30, 2019
Est. primary completion date December 31, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Months to 24 Months
Eligibility Inclusion Criteria: - Children aged from 6 to 24 months olds. - Moderate acute malnutrition defined by a -3 = Weight/Height z-score < -2 SD. - Written informed consent of parents or legal guardian. - Child able to be brought back to the centre on the two following days of inclusion. - Child able to be followed up during at least three months. Exclusion Criteria: - Severe malnutrition defined by a mid upper arm circumference < 115 mm OR Weight/Height z-score < -3 SD OR presence of nutritional oedema. - Clinical complications or according to the physician any clinical sign requiring care outside of the recruitment centre (referral to specialised centre or hospitalisation) - Diarrhea with mucus and bloody stools. - Current incompatible treatment : Antacids, Cetirizine, Digoxin, Ergotamine, Azidothymidine. - Known hypersensitivity to macrolides or albendazole (or one of its components) - Known allergy to enriched flours or prebiotics used in the study, or one of its components.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Azythromycin
Administration of azythromycin to the child at inclusion (3 days) 20 mgs/kgs/day : three days
Dietary Supplement:
Inuline and fructo-oligosaccharides
Administration of inuline and fructo-oligosaccharides (Synergy1) 2g/day, mixed with the fortified blend flour given to the child through the whole intervention.
Drug:
Albendazole
Administration of Albendazole at inclusion of the child : 200mgs, one administration
Dietary Supplement:
Fortified blend flour
Children from 6 to 11 months : 200 grams / day Children from 12 to 24 months : 300 grams / day Compostion of the fortified blend flour per 100 grams : either : Mil (whole grains): 58,56 g/100g, Soybeans (fat meal): 16,54g/100g Peanuts (roasted seeds): 8,75g/100g, Cane sugar: 7,35 g/100g Whole milk (Powder): 7,56g/100g, MSV MAM: 0,28g/100g, iodized salt :0,45g/100g, CaC03: 0,48g/100g,Amylase BAN: 0,03g/100g OR Corn (whole grains): 53,29g/100g, Soybeans (dry seeds): 17,82g/100g, Peanuts (roasted seeds): 9,00 g/100g, Cane sugar: 11,00 Whole milk (Powder): 5,00g/100g, Soybean Oil (Purified): 1,24g/100g, Peanut oil (Purified): 1,13g/100g, MSV MAM: 0,27g/100g, iodized salt: 0,53 g/100g, Ca3(PO4)2: 0,62g/100g, KCl: 0,09g/100g

Locations

Country Name City State
Central African Republic Institut Pasteur de bangui - Centre Nutritionnel de Gbangouma et Centre de Santé Saint-Joseph Bangui
Madagascar Institut Pasteur de Madagascar - CRENAM Andohotapenaka et Centre de Santé Mitia Antananarivo
Niger Centre de santé intégré ACF de Tchake et d'Issawanne Maradi
Senegal Institut Pasteur de Dakar - Poste de Santé Hamo V Dakar Guédiawaye

Sponsors (6)

Lead Sponsor Collaborator
Institut Pasteur Action Contre la Faim, Centre de Recherches Médicales et Sanitaires CERMES Niger, Institut Pasteur de Bangui, Institut Pasteur de Dakar, Institut Pasteur de Madagascar

Countries where clinical trial is conducted

Central African Republic,  Madagascar,  Niger,  Senegal, 

Outcome

Type Measure Description Time frame Safety issue
Primary Recovery at three month Recovery at three months, defined by: Weight/Size Z-score = -1.5 SD measured at 2 following consultations without hospitalization, transfer, death or lost to follow up Three month
Secondary Cognitive-motor development (Senegal) Developmental Milestones Checklist II (DMC II) questionnaire to evaluate participating children cognitive and motor abilities. Baseline, three, six and nine months after inclusion
Secondary Comparison of the Operational Taxonomic Unit composition of stool samples according to the nutritional status Each sample will be ADN extracted using Quiagen technology 16S and 18S amplification will be conducted following Hughert et al. (2014) and Tang et al. (2015). PCR products will be sequenced using NGS Illumina plateform. Sequences will be analyzed using Mothur 1.37.6 software and Silva data base (https://www.arb-silva.de/browser). OTU (Operational Taxonomic Unit) composition will be determined for each sample.
OTU composition of samples from well and malnourished children will be compared using mann whitney test, and shift in OTUs during renutrition will be analysed using survival analysis.
Baseline, three and six months after inclusion
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06056089 - Modified Dosage for Moderate Acute Malnutrition (MODAM-MAM) N/A
Not yet recruiting NCT06038071 - Family Mid-Upper Arm Circumference (MUAC) Follow-up After Recovery From Acute Malnutrition (MODAM-fMUAC) N/A
Completed NCT02571764 - Supplementary Food for Moderate Acute Malnutrition in Children N/A
Recruiting NCT06002438 - Eggs for Gut Health N/A
Completed NCT02272543 - Acceptability and Efficacy of 'Fish Surimi Peptide' in Under Five Children Suffering From Moderate Acute Malnutrition Phase 1
Not yet recruiting NCT06045104 - Alternative Feeding Regimen on Recovery of Children Aged 6-59 Months With Moderate Acute Malnutrition in Bangladesh. N/A
Recruiting NCT06214897 - Choline to Prevent SAM in Children With MAM N/A
Completed NCT03751475 - Optimizing Acute Malnutrition Management in Children Aged 6 to 59 Months in Democratic Republic of Congo N/A
Completed NCT01115647 - Treating Moderate Malnutrition in 6-24 Months Old Children N/A
Completed NCT01898871 - Effectiveness of Nutritional Products to Treat Moderate Acute Malnutrition Phase 2
Completed NCT01147198 - Ready to Use Supplementary Food in Moderate Childhood Malnutrition N/A
Not yet recruiting NCT06305442 - Microbiota Directed Food for Children With Moderate Acute Malnutrition N/A
Terminated NCT03087097 - Transfer of Healthy Gut Flora for Restoration of Intestinal Microbiota Via Enema for Patients in the Rehabilitative Phase of Malnutrition Phase 1
Completed NCT03146897 - Comparison of Four Different Supplementary Foods in the Treatment of Moderate Acute Malnutrition N/A